David Reynolds

Fundador en

Loqus23 Therapeutics Ltd.

53 años

Finance

Health Technology

Perfil

David Reynolds is the founder of Loqus23 Therapeutics Ltd. and holds the title of Chief Executive Officer & Director since 2019.
Dr. Reynolds is currently a Venture Partner at SV Health Investors LLP.

Cargos activos de David Reynolds

Empresas	Cargo	Inicio
SV Health Investors LLP SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements.	Inversor de Capital Privado	-
Loqus23 Therapeutics Ltd. Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology	Fundador	01/01/2019

Todos los cargos activos de David Reynolds

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Reynolds.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
SV Health Investors LLP SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements.	Finance
Loqus23 Therapeutics Ltd. Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology	Health Technology